Novartis announced on Wednesday that the FDA granted Breakthrough Therapy designation to an experimental therapy that targets advanced castration-resistant prostate cancer. The agency said the decision was based on positive data from a Phase 3 clinical trial evaluating LuPSMA-617. Breakthrough Therapy designation is granted to medicines being evaluated for serious …
Read More »CDC panel to discuss COVID-19 vaccination, rare heart issues
Reports of heart inflammation among a small fraction of Pfizer and Moderna infectious-disease infectious-diseaserecipients, predominantly males under 30, are under review as an advisory panel to the Centers for Disease Control and Prevention is set to meet Friday to further discuss the issue. Dr. Tom Shimabukuro, deputy director of the …
Read More »US deaths from heart disease and diabetes climbed amid COVID
NEW YORK – The U.S. saw remarkable increases in the death rates for heart-health” target=”_blank”>heart disease< and some other common killers in 2020, and experts believe a big reason may be that many people with dangerous symptoms made the lethal mistake of staying away from the hospital for fear of …
Read More »What is 'dry scooping'? Latest TikTok trend could be dangerous for your heart
TikTok is chock-full of so-called “life hacks” and fitness trends, but one alleged tip involving “dry scooping” reportedly caused major health issues for at least two users, including one who claims she had a heart attack. So what is this latest gimmick, and can it really cause a heart attack? …
Read More »Breast cancer pill shows benefit in certain hard-to-treat cases
A pill has been shown to help keep certain early-stage, hard-to-treat cancer at bay after initial treatment in findings being reported early because they are so promising. Study results were released Thursday by the American Society of Clinical Oncology ahead of its annual meeting and published in the New England …
Read More »FDA greenlights targeted therapy for lung cancer mutation
The Food and Drug Administration has approved the first drug for a specific mutation causing lung cancer in adults who have undergone at least one systemic treatment, such as chemotherapy. U.S. regulators approved a 960 milligram dose of Lumakras (sotorasib) to battle non-small cell lung cancer with tumors involving a …
Read More »Vietnam detects new coronavirus variant, hybrid of UK, India strains
Vietnam has discovered a new infectious-disease variant that’s a hybrid of strains first found in India and the U.K., the Vietnamese health minister said Saturday. Nguyen Thanh Long said scientists examined the genetic makeup of the virus that had infected some recent patients, and found the new version of the …
Read More »CDC loosens mask requirements for summer camps
The Centers for Disease Control and Prevention (CDC) updated summer camp guidelines on Friday to include situations in which everyone is “fully vaccinated prior to the start of camp.” Under the newly revised guidance, the CDC now says that when everyone at camp is vaccinated it is “safe to return …
Read More »CDC releases guidance on heart inflammation after COVID-19 vaccine
The Centers for Disease Control and Prevention (CDC) has released clinical recommendations for the management of myocarditis and pericarditis, inflammation of the heart, in vaccinated individuals following news that the agency was investigating a small number of young adults and adolescents who may have experienced heart problems following a infectious-disease vaccination. …
Read More »Nearly half of COVID-19 patients experience functional decline after hospital stay
A study of infectious-disease survivors found that up to 45% of those who were hospitalized for the virus experienced a significant functional decline after being discharged. Researchers said the findings highlight the need for rehabilitation in this patient population post-release. The study, which was conducted by Michigan Medicine and published …
Read More »